Saturn V Capital Management Lp Top Holdings and 13F Report (2024) About Saturn V Capital Management LpInvestment ActivitySaturn V Capital Management Lp has $279.77 million in total holdings as of September 30, 2024.Saturn V Capital Management Lp owns shares of 25 different stocks, but just 13 companies or ETFs make up 80% of its holdings.Approximately 27.07% of the portfolio was purchased this quarter.About 30.17% of the portfolio was sold this quarter.This quarter, Saturn V Capital Management Lp has purchased 26 new stocks and bought additional shares in 13 stocks.Saturn V Capital Management Lp sold shares of 8 stocks and completely divested from 5 stocks this quarter.Largest Holdings Ascendis Pharma A/S $29,904,553Disc Medicine $25,112,555Vaxcyte $23,423,864CG ONCOLOGY INC $19,624,090Cogent Biosciences $18,499,309 Largest New Holdings this Quarter CG ONCOLOGY INC $19,624,090 HoldingMoonLake Immunotherapeutics $15,074,269 HoldingSilence Therapeutics $8,746,889 HoldingARRIVENT BIOPHARMA INC $1,110,751 Holding Largest Purchases this Quarter CG ONCOLOGY INC 520,119 shares (about $19.62M)MoonLake Immunotherapeutics 298,974 shares (about $15.07M)Ascendis Pharma A/S 87,061 shares (about $13.00M)Silence Therapeutics 481,127 shares (about $8.75M)Phathom Pharmaceuticals 281,284 shares (about $5.09M) Largest Sales this Quarter argenx 42,085 shares (about $22.81M)Crinetics Pharmaceuticals 370,114 shares (about $18.91M)BioMarin Pharmaceutical 141,157 shares (about $9.92M)KalVista Pharmaceuticals 571,989 shares (about $6.62M)iTeos Therapeutics 171,725 shares (about $1.75M) Sector Allocation Over TimeMap of 500 Largest Holdings ofSaturn V Capital Management Lp Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorASNDAscendis Pharma A/S$29,904,553$12,999,078 ▲76.9%200,28510.7%MedicalIRONDisc Medicine$25,112,555$390,761 ▲1.6%511,0419.0%MedicalPCVXVaxcyte$23,423,864$1,221,889 ▼-5.0%204,9878.4%MedicalCG ONCOLOGY INC$19,624,090$19,624,090 ▲New Holding520,1197.0%COMCOGTCogent Biosciences$18,499,309$420,984 ▲2.3%1,712,8996.6%MedicalCARGO THERAPEUTICS INC$18,495,405$2,686,541 ▲17.0%1,002,4616.6%COMCYTKCytokinetics$17,491,742$3,128,242 ▲21.8%331,2836.3%MedicalPHATPhathom Pharmaceuticals$15,812,587$5,085,615 ▲47.4%874,5905.7%MedicalMLTXMoonLake Immunotherapeutics$15,074,269$15,074,269 ▲New Holding298,9745.4%MedicalCELCCelcuity$14,109,855$2,764,225 ▲24.4%946,3355.0%MedicalARGXargenx$11,985,931$22,813,437 ▼-65.6%22,1114.3%MedicalSNDXSyndax Pharmaceuticals$9,663,076$1,584,737 ▲19.6%501,9783.5%MedicalSLNSilence Therapeutics$8,746,889$8,746,889 ▲New Holding481,1273.1%MedicalABIVAX SA$7,465,179$233,384 ▲3.2%648,0192.7%SPONSORED ADSINZYInozyme Pharma$7,158,876$1,195,055 ▲20.0%1,368,8102.6%MedicalMRUSMerus$6,556,750$1,675,309 ▼-20.4%131,2402.3%MedicalKALVKalVista Pharmaceuticals$6,444,143$6,623,633 ▼-50.7%556,4892.3%MedicalNEUMORA THERAPEUTICS INC.$5,719,877$566,868 ▲11.0%432,9962.0%COMCRNXCrinetics Pharmaceuticals$5,598,874$18,912,826 ▼-77.2%109,5672.0%MedicalIRWDIronwood Pharmaceuticals$4,616,085$27,130 ▲0.6%1,120,4091.6%MedicalBMRNBioMarin Pharmaceutical$2,631,095$9,921,924 ▼-79.0%37,4320.9%MedicalITOSiTeos Therapeutics$1,998,138$1,753,312 ▼-46.7%195,7040.7%MedicalCONTINEUM THERAPEUTICS INC$1,479,465$85,479 ▲6.1%77,2970.5%CL AARRIVENT BIOPHARMA INC$1,110,751$1,110,751 ▲New Holding47,2660.4%COMLBPHLongboard Pharmaceuticals$1,050,862$1,330,301 ▼-55.9%31,5290.4%MedicalFOLDAmicus Therapeutics$0$7,078,277 ▼-100.0%00.0%MedicalANABAnaptysBio$0$6,255,202 ▼-100.0%00.0%MedicalELVNEnliven Therapeutics$0$3,556,400 ▼-100.0%00.0%MedicalRAPPORT THERAPEUTICS INC$0$1,628,200 ▼-100.0%00.0%COMMORFMorphic$0$1,623,776 ▼-100.0%00.0%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
